| Financial Year |
March 31 2023 |
| Monetary Funds |
1,092,040,772.26 |
| Held-for-trading Financial Assets |
103,966,604.55 |
| Notes Receivable |
166,284,511.70 |
| Accounts Receivable |
938,541,873.48 |
| Advances to Suppliers |
59,412,212.17 |
| Other Receivables |
17,433,656.03 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
752,280,203.01 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
34,001,970.28 |
| Total Current Assets |
3,284,924,947.14 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
4,899,039.07 |
| Investment Properties |
-- |
| Fixed Assetes |
1,450,684,786.05 |
| Under-construction Projects |
217,704,535.81 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
271,464,845.45 |
| R&D expenses |
-- |
| Goodwill |
682,052,777.87 |
| Long-Term Deferred and Prepaid Expenses |
13,699,022.88 |
| Deferred Income Tax Assets |
80,367,742.64 |
| Other Non-Current Assets |
13,689,394.30 |
| Sub-Total of Non-Current Assets |
2,955,927,872.36 |
| Total Assets |
6,240,852,819.50 |
| Short-Term Loans |
906,984,552.30 |
| Trading Financial liabilities |
-- |
| Notes Payable |
49,175,500.50 |
| Accounts Payable |
237,248,508.22 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
40,116,975.84 |
| Taxes Payable |
34,923,766.83 |
| Interest Payable |
2,050,618.45 |
| Dividend Payable |
17,020,434.53 |
| Other payables |
80,296,118.81 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
92,653,801.14 |
| Other Current Liabilities |
71,295,136.01 |
| Sub-Total of Current Liabilities |
1,514,115,572.37 |
| Long-term Loans |
227,729,699.79 |
| Bonds Payable |
520,062,028.12 |
| Long-Term Accounts Payable |
26,029,803.48 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
33,686,542.11 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
851,351,439.06 |
| Total Liabilities |
2,365,467,011.43 |
| Paid-In Capital(Or Share Stock) |
528,652,095.00 |
| Capital Surplus |
1,206,780,539.79 |
| Surplus Reserve |
115,727,901.38 |
| LESS:Treasury Stock |
88,942,284.16 |
| Undistributed Profits |
1,894,624,066.20 |
| Minority Stockholder's Interest |
96,303,950.09 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,779,081,857.98 |
| Owner's Equity（Stockholder's Equity） |
3,875,385,808.07 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,240,852,819.50 |
